Exyte completed the acquisition of TTP Group.

Exyte, a provider of engineering, design, and delivery of high-tech facilities, completed the acquisition of TTP Group, a provider of consulting and engineering for the pharmaceutical and chemical industry in Europe. Financial terms were not disclosed. "This strategic move is an important step for Exyte on our 'Pathway to Ten' and aligns perfectly with our future agenda 'Next Level'. By combining TTP's engineering expertise with Exyte's project execution capabilities, we will strengthen our presence in Europe's biotech and pharma sectors, offering clients comprehensive support from strategic planning to facility delivery," Wolfgang Büchele, Exyte CEO.